These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 17281655)

  • 1. Glioblastoma multiforme treated by the chemotherapeutic agent temozolomide in vivo: a 4D simulation model of the tumor response.
    Antipas VP; Stamatakos GS; Uzunoglu NK
    Conf Proc IEEE Eng Med Biol Soc; 2005; 2005():6100-3. PubMed ID: 17281655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A spatiotemporal, patient individualized simulation model of solid tumor response to chemotherapy in vivo: the paradigm of glioblastoma multiforme treated by temozolomide.
    Stamatakos GS; Antipas VP; Uzunoglu NK
    IEEE Trans Biomed Eng; 2006 Aug; 53(8):1467-77. PubMed ID: 16916081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simulating chemotherapeutic schemes in the individualized treatment context: the paradigm of glioblastoma multiforme treated by temozolomide in vivo.
    Stamatakos GS; Antipas VP; Uzunoglu NK
    Comput Biol Med; 2006 Nov; 36(11):1216-34. PubMed ID: 16207487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A patient-specific in vivo tumor and normal tissue model for prediction of the response to radiotherapy.
    Stamatakos G; Antipas VP; Ozunoglu NK
    Methods Inf Med; 2007; 46(3):367-75. PubMed ID: 17492124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Image-driven modeling of the proliferation and necrosis of glioblastoma multiforme.
    Patel V; Hathout L
    Theor Biol Med Model; 2017 May; 14(1):10. PubMed ID: 28464925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A four-dimensional computer simulation model of the in vivo response to radiotherapy of glioblastoma multiforme: studies on the effect of clonogenic cell density.
    Stamatakos GS; Antipas VP; Uzunoglu NK; Dale RG
    Br J Radiol; 2006 May; 79(941):389-400. PubMed ID: 16632619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse.
    Brada M; Hoang-Xuan K; Rampling R; Dietrich PY; Dirix LY; Macdonald D; Heimans JJ; Zonnenberg BA; Bravo-Marques JM; Henriksson R; Stupp R; Yue N; Bruner J; Dugan M; Rao S; Zaknoen S
    Ann Oncol; 2001 Feb; 12(2):259-66. PubMed ID: 11300335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Numerical Handling of the Boundary Conditions Imposed by the Skull on an Inhomogeneous Diffusion-Reaction Model of Glioblastoma Invasion Into the Brain: Clinical Validation Aspects.
    Stamatakos GS; Giatili SG
    Cancer Inform; 2017; 16():1176935116684824. PubMed ID: 28469383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Temozolomide, an oral chemotherapeutic agent with potential severe toxicity].
    Soetekouw PM; Gijtenbeek JM; van der Maazen RW; Kappelle AC; van Herpen CM
    Ned Tijdschr Geneeskd; 2007 Jan; 151(4):253-7. PubMed ID: 17323884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling tumor growth and irradiation response in vitro--a combination of high-performance computing and web-based technologies including VRML visualization.
    Stamatakos GS; Zacharaki EI; Makropoulou MI; Mouravliansky NA; Marsh A; Nikita KS; Uzunoglu NK
    IEEE Trans Inf Technol Biomed; 2001 Dec; 5(4):279-89. PubMed ID: 11759834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy in the treatment of recurrent glioblastoma multiforme: ifosfamide versus temozolomide.
    Paulsen F; Hoffmann W; Becker G; Belka C; Weinmann M; Classen J; Kortmann RD; Bamberg M
    J Cancer Res Clin Oncol; 1999 Jul; 125(7):411-8. PubMed ID: 10394962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvage chemotherapy with cyclophosphamide for recurrent, temozolomide-refractory glioblastoma multiforme.
    Chamberlain MC; Tsao-Wei DD
    Cancer; 2004 Mar; 100(6):1213-20. PubMed ID: 15022289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A four-dimensional simulation model of tumour response to radiotherapy in vivo: parametric validation considering radiosensitivity, genetic profile and fractionation.
    Dionysiou DD; Stamatakos GS; Uzunoglu NK; Nikita KS; Marioli A
    J Theor Biol; 2004 Sep; 230(1):1-20. PubMed ID: 15275995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating a signature of temozolomide resistance in GBM cell lines using metabolomics.
    St-Coeur PD; Poitras JJ; Cuperlovic-Culf M; Touaibia M; Morin P
    J Neurooncol; 2015 Oct; 125(1):91-102. PubMed ID: 26311249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coupling biomechanics to a cellular level model: an approach to patient-specific image driven multi-scale and multi-physics tumor simulation.
    May CP; Kolokotroni E; Stamatakos GS; Büchler P
    Prog Biophys Mol Biol; 2011 Oct; 107(1):193-9. PubMed ID: 21740923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of glioblastoma cell killing by combination treatment with temozolomide and tamoxifen or hypericin.
    Gupta V; Su YS; Wang W; Kardosh A; Liebes LF; Hofman FM; Schönthal AH; Chen TC
    Neurosurg Focus; 2006 Apr; 20(4):E20. PubMed ID: 16709026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway.
    Bi Y; Li H; Yi D; Sun Y; Bai Y; Zhong S; Song Y; Zhao G; Chen Y
    Mol Pharm; 2018 Nov; 15(11):4912-4925. PubMed ID: 30336060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A spatio-temporal simulation model of the response of solid tumours to radiotherapy in vivo: parametric validation concerning oxygen enhancement ratio and cell cycle duration.
    Antipas VP; Stamatakos GS; Uzunoglu NK; Dionysiou DD; Dale RG
    Phys Med Biol; 2004 Apr; 49(8):1485-504. PubMed ID: 15152687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canadian recommendations for the treatment of glioblastoma multiforme.
    Mason WP; Maestro RD; Eisenstat D; Forsyth P; Fulton D; Laperrière N; Macdonald D; Perry J; Thiessen B;
    Curr Oncol; 2007 Jun; 14(3):110-7. PubMed ID: 17593983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined modality treatment of glioblastoma multiforme: the role of temozolomide.
    Nieder C; Adam M; Grosu AL
    Rev Recent Clin Trials; 2006 Jan; 1(1):43-51. PubMed ID: 18393779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.